Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
brain-stimulation
Press Release
Apr 7, 2022
Seattle Police Department Partners With Fisher Wallace to Improve Officer Wellness
The launch of a study with clinical oversight from Washington State University marks the commencement of this partnership between SPD and Fisher Wallace
Read More
Press Release
Mar 29, 2022
Fisher Wallace Completes 2.5 Million Dollar Investment From SHUFL Capital
The investment comes at a time of growth for Fisher Wallace with the launch of an equity crowdfunding campaign through StartEngine
Read More
Press Release
Jan 25, 2022
Actipulse Neuroscience Joins Y Combinator
By joining the ranks of Y Combinator's Winter 22 batch, Actipulse Neuroscience is ready to accelerate the development of its clinical pipeline, most notably the start of their FDA pivotal trial to bring their proprietary non-invasive brain neuromodulation technology to the home of patients diagnosed with Major Depressive Disorder.
Read More
Press Release
Sep 30, 2021
Actipulse Neuroscience Announces Successful Clinical Trial Using Fast Gamma Magnetic Stimulation for the Treatment of Alzheimer's Disease
This trial marks the first step taken by Actipulse Neuroscience to use a new method of neuromodulation to stop or slow Alzheimer's disease, an issue that fails to be solved by anything currently available on the market
Read More
Press Release
Dec 18, 2019
Sooma Closes an Investment Round of Over 1.2 Million EUR
Read More
Press Release
Nov 28, 2018
Soterix Medical Awarded Patent for Advanced Non-Invasive Stimulation Electrodes
Read More
Press Release
Jul 29, 2015
Neuroscience Experts to Congregate in Barcelona, Spain on 3rd and 4th December 2015
Neuroscience R&D Technologies Conference to be held in Barcelona, Spain on 3 - 4 December 2015 will gather global neuroscience experts to discuss developments in brain imaging, animal models, neurogames, neuroinformatics and neuromodulation among others.
Read More
Press Release
Mar 24, 2014
Beckman Institute Initiates Study Using Soterix Medical HD-tDCS for Fluid Intelligence: $12.7million in Funding Through IARPA
Soterix Medical Inc. announces a multidisciplinary study based at the University of Illinois Beckman Institute to determine if High-Definition tDCS (HD-tDCS) in conjunction with other interventions improves adaptive reasoning and fluid intelligence.
Read More
First
Prev
1
Next
Last